Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 29.16M P/E - EPS this Y 82.70% Ern Qtrly Grth -
Income -84.94M Forward P/E -0.70 EPS next Y 42.60% 50D Avg Chg -47.00%
Sales 16.75M PEG 0.00 EPS past 5Y - 200D Avg Chg -76.00%
Dividend N/A Price/Book 0.50 EPS next 5Y 215.30% 52W High Chg -96.00%
Recommedations 2.00 Quick Ratio 2.97 Shares Outstanding 53.52M 52W Low Chg 1.00%
Insider Own 3.02% ROA -40.86% Shares Float 51.94M Beta -
Inst Own 29.75% ROE -156.71% Shares Shorted/Prior 1.82M/3.15M Price 0.54
Gross Margin 82.21% Profit Margin - Avg. Volume 2,831,998 Target Price 5.50
Oper. Margin -368.84% Earnings Date Mar 2 Volume 2,015,346 Change -9.18%
VYNE Therapeutics Inc. News
01/19/22 VYNE Therapeutics Announces Phase 1b Data for FMX114 from Phase 1b/2a Trial for the Treatment of Mild-to-Moderate Atopic Dermatitis
01/13/22 VYNE Therapeutics Divests Topical Minocycline Assets
01/03/22 VYNE Therapeutics to Participate at the LifeSci Partners 11th Annual Corporate Access Event
12/13/21 Do Options Traders Know Something About VYNE Therapeutics (VYNE) Stock We Don't?
11/18/21 VYNE Therapeutics to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference
11/12/21 VYNE Therapeutics (NASDAQ:VYNE) investors are sitting on a loss of 80% if they invested a year ago
11/10/21 VYNE Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Update
11/04/21 Lead BET Inhibitor, VYN201, Demonstrates Improvement in Reducing Fibrotic Tissue Mass and Overall Skin Repair Outcomes in Preclinical Study
02:05 PM VYNE Therapeutics Inc. (VYNE) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
07:00 AM VYNE Therapeutics to Report Third Quarter 2021 Financial Results on November 10, 2021
10/26/21 Lead BET Inhibitor, VYN201, Significantly Reduces Expression of Several Key Pro-Inflammatory Cytokines in Preclinical Studies
10/21/21 VYNE Therapeutics Announces Formation of Scientific Advisory Board
10/19/21 VYNE Therapeutics Enrolls First Patient in Clinical Trial of FMX114 for the Treatment of Mild-to-Moderate Atopic Dermatitis
10/05/21 VYNE Therapeutics Announces its China Partner’s Enrollment of First Patient in Phase 3 Study of AMZEEQ® in Patients with Moderate to Severe Acne
09/20/21 VYNE Therapeutics to Present at the Cantor Fitzgerald Investment Conference
09/08/21 VYNE Therapeutics to Present at the H.C. Wainwright Annual Investment Conference
08/13/21 Revenue Downgrade: Here's What Analysts Forecast For VYNE Therapeutics Inc. (NASDAQ:VYNE)
08/12/21 VYNE Therapeutics Reports Second Quarter 2021 Financial Results and Announces New Strategic Direction to Develop Treatments for Immunological and Inflammatory Diseases
08/12/21 VYNE Therapeutics Announces Licensing of BET Inhibitor Platform for Immuno-Inflammatory Conditions with In4Derm Limited

VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing and commercializing various therapeutics for dermatology. The company offers AMZEEQ, a topical minocycline used for the treatment of inflammatory lesions of non-nodular moderate-to-severe acne vulgaris in patients 9 years of age and older; and ZILXI for the treatment of inflammation lesions of papulopustular rosacea in adults. It is also developing FCD105, a topical combination foam that has completed Phase II clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, which is in preclinical trial for the treatment of mild-to-moderate atopic dermatitis. The company was formerly known as Menlo Therapeutics Inc. and changed its name to VYNE Therapeutics Inc. in September 2020. VYNE Therapeutics Inc. was founded in 2003 and is based in Bridgewater, New Jersey.

VYNE Chatroom

User Image DrAzstarys Posted - 57 minutes from now

$VYNE Renaissance Technologies seems to like the cheap shares. They increased their holding by 300%. Lets see if they sold some in Q4 for tax loss or if they increased it again. They did the same with Aclaris. Buying when its cheap then pushing it up and then selling.

User Image Gasbag150 Posted - 6 minutes from now

$VYNE I'm holding in the hope that some outfit will come and gobble this crap up

User Image Pol8490 Posted - 21 minutes ago

$VYNE scamcompany!! ShitCEO and staff!!

User Image Bakedpotat0 Posted - 56 minutes ago

$VYNE worse than doge coin 🤣

User Image BryGuy91 Posted - 4 hours ago

$VYNE Delisting if they continue on their same path.

User Image stocktowatch7 Posted - 5 hours ago

$VYNE, $COTY here goes on http://www.stocksequity.com/active-stocks/lumpy-stock-vyne-therapeutics-inc-nasdaqvyne-coty-inc-nysecoty/

User Image looking4damoney Posted - 7 hours ago

$VYNE Is the CEO trying to delist this one?

User Image looking4damoney Posted - 7 hours ago

$VYNE Just think. last January this stock was 11.00. How the hell did this crash this bad?

User Image magicseason Posted - 8 hours ago

$VYNE watch closely to their next ER. hope their cash burn rate will go lower than before. otherwise they might not survive in the next 2 years.

User Image Rat808 Posted - 8 hours ago

$VYNE 10

User Image magicseason Posted - 9 hours ago

$VYNE they don't have any income. just curious how long they can burn out their cash in hand. no doubt this is still going down hill. even though the data come out positive. still a pump and down. wont help anything with those who down more than 60%. the bear market will last for at least 2 years.

User Image Spiceman63 Posted - 10 hours ago

$VYNE $.14 pre reverse split

User Image chrisdea Posted - 10 hours ago

$VYNE oh my God, this is too funny... And I'm still holding my bag, too... Sheesh...

User Image Sanetchkin Posted - 11 hours ago

$VYNE Kill yourself Domzalski

User Image Pol8490 Posted - 11 hours ago

$VYNE real scamcompany!

User Image magicseason Posted - 12 hours ago

$VYNE no hope. never too late to exit. i left at 0.78 but that day close above 0.8. I didn't feel any regret b/c now it is down below. we.can see 0.5 is in coming.

User Image 24foryou Posted - 12 hours ago

$VYNE is same thing happened with KALA with 2 approved drug?

User Image Jdat Posted - 14 hours ago

$VYNE is it good to start new position in vyne

User Image Cowboys5 Posted - 14 hours ago

$VYNE the only benefit to selling this today is all my other stocks are down over 50% recently so the gaps closed. So I’m theory $VYNE isn’t looking so shit. I’m tempted to sell and lump into cannabis plays with mid terms this year. 🤔

User Image Jdat Posted - 14 hours ago

$VYNE should I start a new position here trying to deform clsn it’s trading at .45

User Image Tankatruck Posted - 15 hours ago

$FBIO $PROG Fbio is trading below cash... they have diverse portfolio and like the methodology of how select targets to pursue (diversified baby bio incubator)... they control Derm and other bio companies, helps with risk vs singular platform... discovered when $VYNE unloaded amzeeq/zilixi, the winner in end of that transaction was fbio, im adding ...peace

User Image J_D_mcloven Posted - 15 hours ago

$VYNE I am down 94.08 % from last year. My continued reward for being a dumbass longterm bag holder is that I get to warm my hands on this dumpster fire, while hearing the sweet sensational theories of granduer whispered in my ear by @DrAzstarys as I drink my $3 ripple in the alley. Thanks @Phaaa and @Stockmarketmama for making this fun!!!

User Image DrAzstarys Posted - 16 hours ago

$VYNE lets not forget one of their biggest assets right now is the accumulated deficit of $650 million. That alone makes them a buyout target for every company that makes money and has to pay taxes. Leo Pharma could buy them out and save a lot of taxes. Domzalski could continue as Leo Pharma US CEO since the CEO left the company recently. Almirall could also be interested in VYNE's pipeline because their own pipeline is not good enough for a company with a $2 billion market cap.

User Image DrAzstarys Posted - 16 hours ago

$VYNE i asked Vyne if there are companies who are still using Vyne's technology. The answer was that as of now they still have Leo Pharma and Actavis who use the licensed technology. But its still very early development so its not material information right now. Anybody know who owns Actavis right now? I think its Teva right?

User Image WestBrick Posted - 16 hours ago

$VYNE the CEO is incompetent and refused to step down, a new CEO with qualification will make this ticker turn around, this turd has nothing to contribute to the company and still take 1 million salary every year, does he care about the stock price, apparently not, he still sit pretty. you guys see the problem here? $KPTI was in a swamp until the new CEO has arrived, and their stock price is almost doubled from 4s. the current management in vyne have been sucking the blood from retails for years.

User Image GrimmtheFallen Posted - 17 hours ago

$VYNE let's go....

User Image DrAzstarys Posted - 17 hours ago

$VYNE made a little trade at ARDS over the last days and put the profit into Vyne. Now holding 31k shares. Lets get some good trial results.

User Image GrimmtheFallen Posted - 18 hours ago

$VYNE let's hit a dollar

User Image GrimmtheFallen Posted - 19 hours ago

$VYNE got a little in this let's see how the year goes

User Image Rat808 Posted - 1 day ago

$VYNE 9 lives or cloud 9…Day nein

Analyst Ratings
HC Wainwright & Co. Buy May 7, 21